Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
The challenge of approving add-on therapies for patients with metastatic cancer
Dr David Montgomery, Alexander Smith
The challenge of approving add-on therapies for patients with metastatic cancer ( Dr David Montgomery, Alexander Smith )
5 Jul 2017
Biomarker research in breast cancer
Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium
Biomarker research in breast cancer ( Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium )
4 Jul 2017
New biomarkers for response to immunotherapy
Prof Antoni Ribas - University of California, Los Angeles, USA
New biomarkers for response to immunotherapy ( Prof Antoni Ribas - University of California, Los Angeles, USA )
4 Jul 2017
Current and future immune approaches in precision medicine
Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France
Current and future immune approaches in precision medicine ( Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France )
4 Jul 2017
Precision medicine enabled histology agnostic development of immunotherapeutics
Dr Roy Baynes - Merck Research Laboratories, Rahway, USA
Precision medicine enabled histology agnostic development of immunotherapeutics ( Dr Roy Baynes - Merck Research Laboratories, Rahway, USA )
4 Jul 2017
Patient-specific peptide vaccines
Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany
Patient-specific peptide vaccines ( Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany )
4 Jul 2017
Latest maintenance strategies in multiple myeloma
Prof Guillermo Ruiz-Arguelles and Prof McCarthy
Latest maintenance strategies in multiple myeloma ( Prof Guillermo Ruiz-Arguelles and Prof McCarthy )
25 Jun 2017
Front-line combinations in multiple myeloma: Highlights from EHA 2017
Prof Joy Ho and Prof Je-Jung Lee
Front-line combinations in multiple myeloma: Highlights from EHA 2017 ( Prof Joy Ho and Prof Je-Jung Lee )
25 Jun 2017
Latest in relapsed and refractory multiple myeloma
Prof Heinz Ludwig, Prof Wee Joo Chng and Prof James Chim
Latest in relapsed and refractory multiple myeloma ( Prof Heinz Ludwig, Prof Wee Joo Chng and Prof James Chim )
25 Jun 2017
Denosumab or zoledronic acid for bone disease in multiple myeloma
Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Denosumab or zoledronic acid for bone disease in multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
25 Jun 2017
Extended followup indicates daratumumab with bortezomib and dexamethasone for...
Prof Katja Weisel - University of Tübingen, Tübingen, Germany
Extended followup indicates daratumumab with bortezomib and dexamethasone for relapsed MM ( Prof Katja Weisel - University of Tübingen, Tübingen, Germany )
24 Jun 2017
Phase Ib/II study of nivolumab in combination with azacytidine in patients with...
Prof Naval Daver - MD Anderson Cancer Center, Houston, USA
Phase Ib/II study of nivolumab in combination with azacytidine in patients with relapsed AML ( Prof Naval Daver - MD Anderson Cancer Center, Houston, USA )
24 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation